Diphenhydramine/Lorazepam/Zolpidem

苯海拉明/劳拉西泮/唑吡坦

Report date: 2024/04/18 20:00:32

Base Information

Drug NameDiphenhydramine/Lorazepam/Zolpidem
Drug Alias Name劳拉西泮/唑吡坦/苯海拉明Lorazepam/Zolpidem/Diphenhydramine苯海拉明劳拉西泮唑吡坦Diphenhydramine/Zolpidem/Lorazepam劳拉西泮唑吡坦苯海拉明 +[7] 
ClassificationSmall molecules
Mechanisms of ActionHistamine H1 receptor inverse agonistsGamma-aminobutyric acid A receptor agonists
TargetsHistamine H1 receptorGamma-aminobutyric acid A receptor
Therapy Area/IndicationsSleep Initiation and Maintenance Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsYes LorazepamZolpidem TartrateDiphenhydramine Hydrochloride
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSequential Medicine Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSequential Medicine Ltd
Active IndicationsN/A
Inactive IndicationsSleep Initiation and Maintenance Disorders

Other Information

ATC CodeN/A
Related LinksN/A